SAN FRANCISCO – Chemoradiation with FOLFOX and cetuximab was effective in adults with locally advanced cardia and esophageal cancer in a phase 2 study, according to Aimery de Gramont, MD. Now, researchers want to see the regimen evaluated in a phase 3 trial.
FOLFOX plus cetuximab produced ORR of 77% in cardia, esophageal cancer